David Curiel

David Curiel is a prominent figure in the field of gene therapy, virotherapy, and vaccinology. With a strong emphasis on academic entrepreneurship, he has successfully established centers for gene therapy and biologic therapy within the school of medicine. His notable ventures include founding biotech companies like Altimmune, Inc., DNAtrix, Inc., Unleash Immuno Oncolytics, Inc., and Precision Virologics, Inc. David Curiel's translational approach has led to the development and implementation of six original gene therapies from bench to bedside. His out-of-the-box thinking is exemplified through his involvement in the One Health initiative, focusing on human-animal impacts in the St. Louis ecosystem.